US Patent Issued to The University of Chicago on Aug. 5 for "Use of bromodomain-containing protein 9 inhibitors to treat and/or prevent uterine leiomyosarcoma" (Illinois Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,377,103, issued on Aug. 5, was assigned to The University of Chicago (Chicago).

"Use of bromodomain-containing protein 9 inhibitors to treat and/or prevent uterine leiomyosarcoma" was invented by Qiwei Yang (Bolingbroke, Ill.) and Ayman Al-Hendy (Hinsdale, Ill.).

According to the abstract* released by the U.S. Patent & Trademark Office: "In aspects, the present disclosure provides a method of treating or preventing a uterine leiomyosarcoma in a female mammal, the method comprising, consisting essentially of, or consisting of administering to the female mammal an effective amount of an inhibitor of bromodomain-containing protein 9 (BRD9)."

The patent was filed on June 30, 2023, under ...